chr8-41932020-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006766.5(KAT6A):c.*185C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.201 in 542,170 control chromosomes in the GnomAD database, including 12,962 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2777 hom., cov: 31)
Exomes 𝑓: 0.21 ( 10185 hom. )
Consequence
KAT6A
NM_006766.5 3_prime_UTR
NM_006766.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.17
Genes affected
KAT6A (HGNC:13013): (lysine acetyltransferase 6A) This gene encodes a member of the MOZ, YBFR2, SAS2, TIP60 family of histone acetyltransferases. The protein is composed of a nuclear localization domain, a double C2H2 zinc finger domain that binds to acetylated histone tails, a histone acetyl-transferase domain, a glutamate/aspartate-rich region, and a serine- and methionine-rich transactivation domain. It is part of a complex that acetylates lysine-9 residues in histone 3, and in addition, it acts as a co-activator for several transcription factors. Allelic variants of this gene are associated with an autosomal dominant form of cognitive disability. Chromosomal translocations of this gene are associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 8-41932020-G-C is Benign according to our data. Variant chr8-41932020-G-C is described in ClinVar as [Benign]. Clinvar id is 1247574.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.238 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAT6A | NM_006766.5 | c.*185C>G | 3_prime_UTR_variant | 17/17 | ENST00000265713.8 | NP_006757.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KAT6A | ENST00000265713 | c.*185C>G | 3_prime_UTR_variant | 17/17 | 1 | NM_006766.5 | ENSP00000265713.2 | |||
KAT6A | ENST00000406337 | c.*185C>G | 3_prime_UTR_variant | 18/18 | 5 | ENSP00000385888.2 | ||||
KAT6A | ENST00000396930 | c.*185C>G | 3_prime_UTR_variant | 18/18 | 5 | ENSP00000380136.3 | ||||
KAT6A | ENST00000649817 | c.*185C>G | 3_prime_UTR_variant | 11/11 | ENSP00000497780.1 |
Frequencies
GnomAD3 genomes AF: 0.165 AC: 24955AN: 151432Hom.: 2777 Cov.: 31
GnomAD3 genomes
AF:
AC:
24955
AN:
151432
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.215 AC: 83889AN: 390620Hom.: 10185 Cov.: 6 AF XY: 0.214 AC XY: 41752AN XY: 195376
GnomAD4 exome
AF:
AC:
83889
AN:
390620
Hom.:
Cov.:
6
AF XY:
AC XY:
41752
AN XY:
195376
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.165 AC: 24947AN: 151550Hom.: 2777 Cov.: 31 AF XY: 0.163 AC XY: 12041AN XY: 74020
GnomAD4 genome
AF:
AC:
24947
AN:
151550
Hom.:
Cov.:
31
AF XY:
AC XY:
12041
AN XY:
74020
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
102
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 17, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at